Your Input is Requested: AQCG Survey on OOS Investigations
Recommendation

20/21 October 2026
Performance Evaluation and Monitoring for compliant Analytical Procedures and Processes
The ECA Analytical Quality Control Group (AQCG) is currently revising and updating its guidance on Out-of-Specification (OOS) results. The goal is to better reflect current industry practices and to provide clear, practical recommendations that are aligned with today’s regulatory expectations.
To support this important activity, AQCG has launched a member survey focusing on how OOS investigations are defined, structured, and performed across the industry. The questionnaire addresses key aspects such as internal SOPs, investigation phases, testing and retesting strategies, hypothesis testing, decision-making processes, and the handling of confirmed or inconclusive OOS results.
All responses will be evaluated in an aggregated and fully anonymized manner. None of the questions are mandatory, and participants may skip any questions they prefer not to answer. At the end of the survey, respondents are also invited to propose additional topics or questions that AQCG should consider in future guidance documents.
Thank you for your valuable time and support.
Related GMP News
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination
30.09.2026The Relationship between the BP and the Ph. Eur.
30.09.2026New Japanese Pharmacopoeia Drafts (September 2026) Open for Public Comment
30.09.2026EMA publishes final ICH M13B Guideline and Q&A on Bioequivalence

